UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000059674
Receipt number R000068260
Scientific Title Study of Type 2 inflammatory COPD
Date of disclosure of the study information 2025/11/07
Last modified on 2025/11/07 07:54:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study on the significance of Type 2 inflammation in chronic obstructive pulmonary disease (COPD) using data from the TRACK study

Acronym

Study of Type 2 inflammatory COPD

Scientific Title

Study of Type 2 inflammatory COPD

Scientific Title:Acronym

Study of Type 2 inflammatory COPD

Region

Japan


Condition

Condition

COPD

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to determine the clinical significance of type 2 inflammatory phenotype stratification in Japanese COPD patients and to verify whether this phenotype stratification can serve as a selection criterion for anti-inflammatory treatment.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The study aims to investigate the clinical characteristics of COPD patients with elevated eosinophil levels.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

COPD patients participating in the TRACK study

Key exclusion criteria

none

Target sample size

572


Research contact person

Name of lead principal investigator

1st name Tomotaka
Middle name
Last name Kawayama

Organization

Kurume University

Division name

Department of medicine

Zip code

8300011

Address

67 Asahi-machi, Kurume

TEL

0942317560

Email

kawayama_tomotaka@med.kurume-u.ac.jp


Public contact

Name of contact person

1st name Tomoataka
Middle name
Last name Kawayama

Organization

Kurume University

Division name

Department of medicine

Zip code

8300011

Address

67 Asahi-machi, Kurume

TEL

0942317560

Homepage URL


Email

kawayama_tomotaka@med.kurume-u.ac.jp


Sponsor or person

Institute

Saga University

Institute

Department

Personal name



Funding Source

Organization

Kurume University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kurume University Clinical Research Center

Address

67 Asahi-machi, Kurume

Tel

0942317200

Email

i_rinri@kurume-u.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

2025-06-R-07

Org. issuing International ID_1

Saga University

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 11 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

572

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2025 Year 06 Month 01 Day

Date of IRB

2025 Year 08 Month 25 Day

Anticipated trial start date

2025 Year 10 Month 31 Day

Last follow-up date

2026 Year 10 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Collaboration between Saga University, Kagoshima University, and the University of Occupational and Environmental Health
Post-hoc study


Management information

Registered date

2025 Year 11 Month 07 Day

Last modified on

2025 Year 11 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068260